US Patent 11352440 Antibodies against CD73 and uses thereof
Patent 11352440 was granted and assigned to Bristol-Myers Squibb on June, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11352440 Antibodies against CD73 and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
